Anaptysbio, Inc Ratios

Ratios Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 22.30%-29.97%-25.53%-300.70%-1,236.96%-1,218.60%-26.57%-91.49%-1,251.09%-953.68%-159.10%
EBIT Margin 30.75%-18.91%-18.13%-287.81%-1,334.44%-1,342.90%-31.84%-89.93%-1,119.41%-958.27%-125.93%
EBITDA Margin 30.75%-30.76%-25.53%-304.96%-1,229.06%-1,209.69%-27.03%-92.15%-1,298.22%-927.73%-157.90%
Operating Margin 30.75%-18.91%-18.13%-287.81%-1,334.44%-1,342.90%-31.84%-89.93%-1,119.41%-958.27%-125.93%
Net Margin 1.46%-30.76%25.53%-300.70%-1,233.12%-1,216.70%-26.57%-91.49%-1,251.33%-953.66%-159.10%
FCF Margin 92.20%-56.52%-54.75%-197.28%-991.38%-879.03%-19.63%-74.85%-718.88%-708.79%-148.66%
Efficiency
Assets Average 195.77M419.18M472.10M425.87M529.81M626.73M531.39M468.11M
Equity Average -47.96M-44.46M134.67M396.97M445.69M400.87M376.58M309.27M175.10M79.49M
Invested Capital -45.26M-50.66M-38.25M307.58M486.37M405.01M396.73M356.43M262.10M88.10M70.87M
Asset Utilization Ratio 0.050.010.020.180.120.020.030.19
Leverage & Solvency
Interest Coverage Ratio -442.73-7.22-6.60-16.21-40.39-103.20
Debt to Equity -0.10-0.360.020.00
Debt Ratio 0.220.020.00
Equity Ratio -0.620.930.960.930.950.550.430.190.15
Times Interest Earned -442.73-7.22-6.60-16.21-40.39-103.20
Valuation
Enterprise Value -22.21M-51.77M-51.29M2,118.28M1,279.40M66.69M194.32M407.80M439.86M178.34M17.50M
Market Capitalization 2,366.69M1,706.48M440.92M587.98M955.90M881.10M569.24M402.88M
Return Ratios
Return on Sales 0.22%-0.31%-0.26%-3.01%-12.33%-12.17%-0.27%-0.91%-12.51%-9.54%-1.59%
Return on Capital Employed -0.16%-0.17%-0.24%-0.06%-0.11%-0.19%-0.33%-0.27%
Return on Invested Capital -0.17%-0.24%-0.94%
Return on Assets -0.15%-0.15%-0.21%-0.05%-0.11%-0.21%-0.31%-0.31%
Return on Equity 0.11%0.10%-0.22%-0.16%-0.22%-0.05%-0.15%-0.42%-0.93%-1.83%